| 000 | 01864 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514032658.0 | ||
| 264 | 0 | _c20020628 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a1350-6277 | ||
| 024 | 7 |
_a10.1177/174182670200900209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHindorff, Lucia A | |
| 245 | 0 | 0 |
_aThe association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular risk _cApr 2002 |
||
| 300 |
_a131-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGene Frequency _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _xcomplications |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aMenopause _xgenetics |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xepidemiology |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 |
_aWashington _xepidemiology |
| 650 | 0 | 4 | _aWomen's Health |
| 700 | 1 | _aSchwartz, Stephen M | |
| 700 | 1 | _aSiscovick, David S | |
| 700 | 1 | _aPsaty, Bruce M | |
| 700 | 1 | _aLongstreth, W T | |
| 700 | 1 | _aReiner, Alexander P | |
| 773 | 0 |
_tJournal of cardiovascular risk _gvol. 9 _gno. 2 _gp. 131-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/174182670200900209 _zAvailable from publisher's website |
| 999 |
_c11905703 _d11905703 |
||